Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of Oncology
Published October 25, 2026
Pembrolizumab plus lenvatinib with belzutifan or quavonlimab as first-line therapy for advanced r...
October 26, 2026
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 26, 2026
00:00
--:--
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplif...
October 26, 2026
Share
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.
https://www.medspoke.co/channel_journal?id=686&tap_id=16328
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published October 26, 2026
Efficacy and Safety of Lonapegsomatropin in Children With Turner Syndrome: 52-Week Results From t...
October 26, 2026
Why are you reporting this TALK?
